ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2026
[Gene doping: current test methods and analytical challenges].
Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gene doping refers to the use of gene therapeutic substances or technologies for the purpose of illicit sport performance enhancement. A wide variety of doping analytical detection methods are currently under development, ranging from PCR (Polymerase Chain Reaction) to high-resolution mass spectrometry to clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated (CRISPR/Cas)-based detection methods. Due to the diverse approaches in gene therapy clinical research, it can be assumed that a wide variety of methods will also be needed to detect cases of gene doping. The increasing availability of unapproved gene doping-related products on the open consumer market underscores the urgent need to establish new detection methods for routine doping control analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.